img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
September 21, 2021
img
img
HHG Capital Corp.
(Nasdaq: HHGCU)

$57,500,000

SPAC IPO

Joint Bookrunner

September 17, 2021
img
img
Guardforce AI Co., Ltd.
(Nasdaq: GFAI)

$15,000,000

Underwritten Public Offering
and Uplisting

Sole Bookrunner

September 10, 2021
img
img
LifeMD, Inc.
(Nasdaq: LFMD)

$35,000,000

Preferred Stock Offering
Joint Bookrunner

September 3, 2021
img
img
Digital Brands Group, Inc.
(Nasdaq: DBGI)

$5,265,000

Private Placement

Exclusive Placement Agent

September 2, 2021
img
img
Digital World Acquisition Corp.
(Nasdaq: DWACU)

$287,500,000

SPAC IPO

Sole Bookrunner

September 1, 2021
img
img
Aesther Healthcare Acquisition Corp.
(Nasdaq: AEHAU)

$105,000,000

SPAC IPO

Sole Bookrunner

September 1, 2021
img
img
Pasithea Therapeutics Corp.
(Nasdaq: KTTA)

$24,000,000

Initial Public Offering

Sole Bookrunner

August 26, 2021
img
img
Charah Solutions, Inc.
(NYSE: CHRA)

$135,000,000

Senior Notes

Lead Manager

August 16, 2021
img
img
DatChat, Inc.
(Nasdaq: DATS)

$13,799,999

Initial Public Offering

Lead Bookrunner

August 12, 2021
img
img
PHP Ventures Acquisition Corp.
(Nasdaq: PPHPU)

$57,500,000

SPAC IPO

Sole Bookrunner

August 11, 2021
img
img
Pono Capital Corp.
(Nasdaq: PONOU)

$115,000,000

SPAC IPO

Sole Bookrunner

August 10, 2021
img
BioVie, Inc.
(Nasdaq: BIVI)

$20,736,000

Underwritten Public Offering

Financial Advisor

1 … 21 22 23 24 25 … 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.